The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists

Human relaxin-2 (relaxin, H2-RLX, RLN2), an endogenous hormone associated with mammalian pregnancy, and its cognate receptor relaxin family peptide receptor 1 (RXFP1) have been implicated as important modulators of cardiovascular function and agonism of RXFP1 may potentially be utilized for the treatment of heart failure. Exploration of chemical space around previously reported anthranilamide <b>2</b> led to the discovery of lead compound <b>39</b> with significantly improved agonist activities toward human and rodent RXFP1. Compound <b>39</b> induced a dose-dependent heart rate increase in isoflurane-anesthetized naïve rats, which is consistent with the hemodynamic profile of relaxin in rat. Compound <b>39</b> also elicited significant interpubic ligament (IPL) expansion in C57BL/6 mouse, measured with microCT imaging, which recapitulated the effect of relaxin.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-05-28
DOI
https://doi.org/10.1021/acs.jmedchem.5c00991
Citations
2
Primary Topic
Pregnancy-related medical research
Type
article
Field-Weighted Citation Impact
3.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists

Ruth R. Wexler, Lei Zhao, R. CHEN, R. Michael Lawrence et al.
2 citations
Journal of Medicinal Chemistry
Pregnancy-related medical research
3.76
article

The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists

Ruth R. Wexler, Lei Zhao, R. CHEN, R. Michael Lawrence, Arvind Mathur, Claudia Generaux, Donna M. Bilder, Michael A. Galella, Michael C. Myers, Thomas Petrone, Carol S. Ryan, Todd J. Friends, Adam Clarke, Shun Su, Jeff Bostwick, Franck Duclos, Anne Rose, Yixin Li, Jianqing Li, Matthew Fronheiser, Cort S. Madsen, Carol Krause
article en
2 citations

Abstract

Human relaxin-2 (relaxin, H2-RLX, RLN2), an endogenous hormone associated with mammalian pregnancy, and its cognate receptor relaxin family peptide receptor 1 (RXFP1) have been implicated as important modulators of cardiovascular function and agonism of RXFP1 may potentially be utilized for the treatment of heart failure. Exploration of chemical space around previously reported anthranilamide <b>2</b> led to the discovery of lead compound <b>39</b> with significantly improved agonist activities toward human and rodent RXFP1. Compound <b>39</b> induced a dose-dependent heart rate increase in isoflurane-anesthetized naïve rats, which is consistent with the hemodynamic profile of relaxin in rat. Compound <b>39</b> also elicited significant interpubic ligament (IPL) expansion in C57BL/6 mouse, measured with microCT imaging, which recapitulated the effect of relaxin.

Journal of Medicinal ChemistryVol. 68(11)
Bristol-Myers Squibb (Germany) (DE), Bristol-Myers Squibb (United States) (US), Bristol-Myers Squibb (Sweden) (SE)
Zero hunger
Openalex Percentile: Top 8%
Pregnancy-related medical research
3.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.